Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > LMDX LumiraDx > Detailed Quotes

LMDX LumiraDx

Watchlist
0.945
+0.015+1.61%
Trading Session  01/31 11:28 ET
High
0.950
Open
0.930
Turnover
15.12K
Low
0.920
Pre Close
0.930
Volume
16.14K
Market Cap
300.22M
P/E(TTM)
Loss
52wk High
9.130
Shares
317.69M
P/E(Static)
Loss
52wk Low
0.771
Float Cap
114.98M
Bid/Ask %
50.00%
Historical High
11.086
Shs Float
121.67M
Volume Ratio
0.48
Historical Low
0.771
Dividend TTM
--
Div Yield TTM
--
P/B
16.58
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.01%
Amplitude
3.23%
Avg Price
0.937
Lot Size
1
Float Cap
114.98M
Bid/Ask %
50.00%
Historical High
11.086
Shs Float
121.67M
Volume Ratio
0.48
Historical Low
0.771
Dividend TTM
--
P/B
16.58
Dividend LFY
--
Turnover Ratio
0.01%
Amplitude
3.23%
Avg Price
0.937
Lot Size
1
Price Forecast

News

Comment

Company Overview More
LumiraDX Ltd. is a next-generation point of care diagnostics company, which engages in the provision of an innovative diagnostic platform that supports a menu of tests with lab-comparable performance at the point of care. The firm's diagnostic testing solutions are being deployed by governments and healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools, and workplaces to screen, diagnose, and monitor wellness as well as disease. It also has a comprehensive portfolio of COVID-19 testing solutions from the lab to point of need. The company was founded by Ronald Zwanziger, David Scott, and Jerry McAleer in 2014 and is headquartered in London, the United Kingdom.
CEO: Mr. Ron Zwanziger
Market: NASDAQ
Listing Date: 03/10/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist